According to Tonix Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.334985. At the end of 2023 the company had a P/S ratio of 3.04.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.04 | |
2022 | N/A | |
2021 | N/A | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | |
2012 | N/A |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Aerie Pharmaceuticals AERI | 3.52 | 951.55% | ๐บ๐ธ USA |
Eagle Pharmaceuticals
EGRX | 0.1937 | -42.17% | ๐บ๐ธ USA |